| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.64 | 0.01 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.44 | 0.01 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |